Trial Profile
NPB-01(Intravenous Immunoglobulin) Therapy for Patients With Bullous Pemphigoid Unresponsive to Corticosteroids: Randomized, Double-Blind, Placebo Control,Parallel Assignment Study(PhaseII).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Bullous pemphigoid
- Focus Therapeutic Use
- Sponsors Nihon Pharmaceutical
- 10 Jun 2014 New trial record